Mijung Lee, MD is a medical oncology internal medicine in Lacey, WA with 16 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. Mijung Lee, MD NPI is 1093970048. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a female.
The provider's business location address is:
4525 3RD AVE SE STE 200
LACEY, WA
ZIP 98503-010
Phone: (360) 754-3934
Fax: (360) 943-8023
The NPI 1093970048 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
- Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
- Injection of different drug or substance into a vein for therapy, diagnosis, or prevention (HCPCS:96375)
- Infusion of chemotherapy into a vein up to 1 hour (HCPCS:96413)
- Insertion of needle into vein for collection of blood sample (HCPCS:36415)
- Injection beneath the skin or into muscle for therapy, diagnosis, or prevention (HCPCS:96372)
- Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour (HCPCS:96365)
The enumeration date for this NPI number is 7/18/2008 and was last updated on 8/11/2022.